Patrik Roser

1.9k total citations
62 papers, 1.4k citations indexed

About

Patrik Roser is a scholar working on Pharmacology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Patrik Roser has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 18 papers in Psychiatry and Mental health and 17 papers in Cognitive Neuroscience. Recurrent topics in Patrik Roser's work include Cannabis and Cannabinoid Research (20 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Schizophrenia research and treatment (8 papers). Patrik Roser is often cited by papers focused on Cannabis and Cannabinoid Research (20 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Schizophrenia research and treatment (8 papers). Patrik Roser collaborates with scholars based in Germany, Switzerland and United Kingdom. Patrik Roser's co-authors include Georg Juckel, Andreas M. Stadelmann, Thomas Nadulski, Martin Brüne, Wolfram Kawohl, Marc‐Andreas Edel, Martin Schnelle, Fritz Pragst, Andreas D. Ebert and Jürgen Gallinat and has published in prestigious journals such as PLoS ONE, Sensors and Psychopharmacology.

In The Last Decade

Patrik Roser

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrik Roser Germany 23 586 339 313 264 260 62 1.4k
Emma Childs United States 26 534 0.9× 338 1.0× 443 1.4× 456 1.7× 140 0.5× 38 2.0k
Mary Kathryn Dahlgren United States 20 766 1.3× 503 1.5× 412 1.3× 336 1.3× 247 0.9× 38 1.6k
Rajiv Radhakrishnan United States 29 1.1k 1.8× 366 1.1× 549 1.8× 495 1.9× 555 2.1× 83 2.5k
Maximilian Pilhatsch Germany 20 329 0.6× 211 0.6× 214 0.7× 236 0.9× 319 1.2× 54 1.3k
Ursula Havemann‐Reinecke Germany 23 376 0.6× 180 0.5× 492 1.6× 254 1.0× 238 0.9× 68 1.8k
Robbert‐Jan Verkes Netherlands 18 250 0.4× 267 0.8× 198 0.6× 361 1.4× 218 0.8× 67 1.1k
José A. Crippa Brazil 24 1.4k 2.4× 539 1.6× 619 2.0× 390 1.5× 396 1.5× 47 2.5k
Anastasia Suraev Australia 18 677 1.2× 187 0.6× 135 0.4× 149 0.6× 121 0.5× 47 991
Leslie H. Lundahl United States 21 315 0.5× 190 0.6× 571 1.8× 311 1.2× 197 0.8× 70 1.5k
Anthony Liguori United States 20 827 1.4× 287 0.8× 332 1.1× 356 1.3× 180 0.7× 48 2.0k

Countries citing papers authored by Patrik Roser

Since Specialization
Citations

This map shows the geographic impact of Patrik Roser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrik Roser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrik Roser more than expected).

Fields of papers citing papers by Patrik Roser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrik Roser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrik Roser. The network helps show where Patrik Roser may publish in the future.

Co-authorship network of co-authors of Patrik Roser

This figure shows the co-authorship network connecting the top 25 collaborators of Patrik Roser. A scholar is included among the top collaborators of Patrik Roser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrik Roser. Patrik Roser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Scherbaum, Norbert, et al.. (2025). Symptom-Triggered Alcohol Detoxification Compared to Fixed-Dose Regimen of Benzodiazepines: A Retrospective Case–Control Study. Brain Sciences. 15(7). 758–758. 1 indexed citations
3.
4.
Scherbaum, Norbert, et al.. (2023). Exploratory Growth Mixture Modeling of Cannabis-Withdrawal Syndrome Trajectories of Adult Pure Cannabis Dependents During Detoxification: Two Subtypes?. Journal of Psychoactive Drugs. 56(4). 1–12. 2 indexed citations
5.
Roser, Patrik, et al.. (2023). Unemployment and Substance Use: An Updated Review of Studies from North America and Europe. Healthcare. 11(8). 1182–1182. 32 indexed citations
6.
Scherbaum, Norbert, et al.. (2022). Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials. Frontiers in Psychiatry. 13. 867878–867878. 10 indexed citations
7.
Habermeyer, Benedikt, Barbara Lay, Norbert Scherbaum, Udo Bonnet, & Patrik Roser. (2022). Referral to aftercare following inpatient withdrawal treatment and readmission: retrospective chart review of patients with substance use disorders. Swiss Medical Weekly. 152(3132). w30213–w30213. 2 indexed citations
8.
Bregenzer, Andrea, et al.. (2022). HCV elimination in a Swiss opioid agonist therapy programme – a cohort study. Swiss Medical Weekly. 152(4950). 40009–40009. 3 indexed citations
9.
Ramseyer, Fabian, Andreas D. Ebert, Patrik Roser, et al.. (2019). Exploring nonverbal synchrony in borderline personality disorder: A double‐blind placebo‐controlled study using oxytocin. British Journal of Clinical Psychology. 59(2). 186–207. 22 indexed citations
10.
Ghio, Marta, et al.. (2019). Moral decision making under modafinil: a randomized placebo-controlled double-blind crossover fMRI study. Psychopharmacology. 236(9). 2747–2759.
11.
Heekeren, Karsten, Patrik Roser, Hélène Haker, et al.. (2019). Early Somatosensory Processing Over Time in Individuals at Risk to Develop Psychosis. Frontiers in Psychiatry. 10. 47–47. 3 indexed citations
12.
Edel, Marc‐Andreas, et al.. (2017). Antidepressive response of inpatients with major depression to adjuvant occupational therapy: a case–control study. Annals of General Psychiatry. 16(1). 1–1. 30 indexed citations
13.
Enzi, Björn, Silke Lissek, Marc‐Andreas Edel, et al.. (2015). Alterations of Monetary Reward and Punishment Processing in Chronic Cannabis Users: An fMRI Study. PLoS ONE. 10(3). e0119150–e0119150. 27 indexed citations
14.
Juckel, Georg, et al.. (2012). Possible association of severe major depression with acute cessation of long-term excessive triptan use. Journal of Clinical Pharmacy and Therapeutics. 38(1). 77–79. 3 indexed citations
15.
Roser, Patrik, et al.. (2011). Nonverbal Behavior During Clinical Interviews. The Journal of Nervous and Mental Disease. 200(1). 26–32. 30 indexed citations
16.
Roser, Patrik, Ida S. Haussleiter, Christoph Maier, et al.. (2011). Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia. Psychopharmacology. 218(4). 611–620. 21 indexed citations
17.
Roser, Patrik, Franz X. Vollenweider, & Wolfram Kawohl. (2010). Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. The World Journal of Biological Psychiatry. 11(2-2). 208–219. 46 indexed citations
18.
Roser, Patrik, et al.. (2009). Psychomotor performance in relation to acute oral administration of Δ9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. European Archives of Psychiatry and Clinical Neuroscience. 259(5). 284–292. 37 indexed citations
19.
20.
Nadulski, Thomas, Frank Sporkert, Martin Schnelle, et al.. (2005). Simultaneous and Sensitive Analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in Plasma after Oral Application of Small Doses of THC and Cannabis Extract. Journal of Analytical Toxicology. 29(8). 782–789. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma Childs Breakdown of academic impact, for papers by Mary Kathryn Dahlgren Breakdown of academic impact, for papers by Rajiv Radhakrishnan Breakdown of academic impact, for papers by Maximilian Pilhatsch Breakdown of academic impact, for papers by Ursula Havemann‐Reinecke Breakdown of academic impact, for papers by Robbert‐Jan Verkes Breakdown of academic impact, for papers by José A. Crippa Breakdown of academic impact, for papers by Anastasia Suraev Breakdown of academic impact, for papers by Leslie H. Lundahl Breakdown of academic impact, for papers by Anthony Liguori
Rankless by CCL
2026